
Mirakle Integrated Health Centre
+91 9344827582
Mon - Sun 9:00 - 6:00
Studies have shown that oxidative stress, chronic inflammation, and cancer are closely linked, with Vitamin C emerging as a potent antioxidant capable of scavenging a wide variety of free radicals and reducing oxidative stress. High dose Vitamin C (IVC) plays a significant role in cancer management by generating hydrogen peroxide, which selectively destroys cancer cells, reducing inflammation, and boosting the immune system. Additionally, high dose Vitamin C can strengthen the collagen capsule surrounding tumors, potentially lowering the chances of metastasis. Administered concurrently with chemotherapy and radiotherapy, typically the day before or after treatment, IVC enhances the efficacy of conventional cancer therapies. At lower doses, Vitamin C functions as an antioxidant, enhancing immune function, reducing fatigue, and aiding in the management and prevention of various diseases, thus improving overall health and vitality.
Oral liposomal vitamin-c
Liposomes are tiny, nano-sized fat-soluble vehicles designed to carry nutrients directly to the body’s cells. Liposomal Vitamin C is encapsulated in a way that mimics the structure of bodily cells, allowing it to pass through the digestive barrier efficiently and deliver the nutrient directly into the bloodstream. This method significantly enhances the absorption rate, achieving approximately 90%, compared to traditional oral Vitamin C supplements.
Intravenous
Intravenous administration of Vitamin C ranges from low doses to high doses, typically between 7.5 grams and 100 grams, depending on the patient’s body weight. The usual dosage is up to 1.5 grams per kilogram of body weight. This tailored approach ensures that patients receive an appropriate and effective amount of Vitamin C based on their individual needs.
Intravenous Vitamin C treatment, aside from its role in cancer management, can be used for various other health conditions, including:
Age-Related Degeneration: Helps combat oxidative stress and slow the aging process.
Cardiovascular Diseases: Supports heart health by reducing oxidative damage and improving blood vessel function.
Inflammatory Disease Conditions: Reduces inflammation and alleviates symptoms associated with conditions like arthritis.
Autoimmune Conditions: Modulates immune system activity and reduces inflammation.
Respiratory Disorders: Enhances immune response and reduces the severity of conditions like asthma and chronic obstructive pulmonary disease (COPD).
Detoxification and Recovery: Aids in detoxifying the body and speeding up recovery from illnesses or surgeries.
Skin Health: Promotes collagen production, improves skin texture, and reduces signs of aging.
Cognitive Health: Supports brain function and may protect against neurodegenerative diseases.
This broad range of applications highlights the potential benefits of intravenous Vitamin C in enhancing overall health and addressing various medical conditions.
High dose Vitamin C treatment can have contraindications, including:
G6PD Deficiency: Patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency may experience hemolysis (destruction of red blood cells) when receiving high doses of Vitamin C.
Iron Overload Disorders: Conditions such as hemochromatosis can be exacerbated by Vitamin C, which enhances iron absorption.
Klimant E, Wright H, Rubin D, Seely D, Markman M. Intravenous vitamin C in the supportive care of cancer patients: a review and rational approach. Curr Oncol. 2018 Apr;25(2):139-148. doi: 10.3747/co.25.3790. Epub 2018 Apr 30. PMID: 29719430; PMCID: PMC5927785.
Ngo B, Van Riper JM, Cantley LC, Yun J. Targeting cancer vulnerabilities with high-dose vitamin C. Nat Rev Cancer. 2019 May;19(5):271-282. doi: 10.1038/s41568-019-0135-7. PMID: 30967651; PMCID: PMC6526932.
Holford P, Carr AC, Jovic TH, Ali SR, Whitaker IS, Marik PE, Smith AD. Vitamin C-An Adjunctive Therapy for Respiratory Infection, Sepsis and COVID-19. Nutrients. 2020 Dec 7;12(12):3760. doi: 10.3390/nu12123760. PMID: 33297491; PMCID: PMC7762433.